{"id":164694,"title":"Economic evidence supplementary appendix : Recommendations for public health programs on the use of pneumococcal vaccines in children - Canada.ca","sourceCode":"hc","sourceName":"Health Canada","language":"en","captureDate":"2025-04-18","captureTimestamp":"2025-04-18T14:19:03.326000+00:00","jobId":1,"originalUrl":"https://www.canada.ca/en/public-health/services/publications/vaccines-immunization/national-advisory-committee-immunization-recommendations-public-health-programs-use-pneumococcal-vaccines-children-including-use-15-valent-20-valent-conjugate-vaccines-economic-evidence-supplementary-appendix.html?wbdisable=true","snippet":"Economic evidence supplementary appendix : Recommendations for public health programs on the use of pneumococcal vaccines in children - Canada.ca Skip to main content Skip to \"About government\" Language selection Français fr / Gouvernement du Canada Search Search Canada.ca Search…","rawSnapshotUrl":"/api/snapshots/raw/164694","browseUrl":"https://replay.healtharchive.ca/job-1/20250418141903/https://www.canada.ca/en/public-health/services/publications/vaccines-immunization/national-advisory-committee-immunization-recommendations-public-health-programs-use-pneumococcal-vaccines-children-including-use-15-valent-20-valent-conjugate-vaccines-economic-evidence-supplementary-appendix.html?wbdisable=true#ha_snapshot=164694","mimeType":"text/html","statusCode":200}